C. Schmults

发表

Effect of Physical Activity on Nonmelanoma Skin Cancer Risk in Kidney, Liver, and Pancreatic Transplant Patients

R. Speck, K. Schmitz, F. M. Whalen, 2010, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Basal cell skin cancer, version 1.2016: Clinical practice guidelines in oncology

T. Olencki, R. Cheney, A. Ho, 2016 .

Test Characteristics of High‐Resolution Ultrasound in the Preoperative Assessment of Margins of Basal Cell and Squamous Cell Carcinoma in Patients Undergoing Mohs Micrographic Surgery

Christopher J. Miller, Daniel B. Shin, A. Jambusaria-Pahlajani, 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Nitric oxide-producing myeloid-derived suppressor cells inhibit vascular E- selectin expression in human squamous cell carcinomas

R. Clark, R. Watanabe, C. Schmults, 2012, The Journal of investigative dermatology.

Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States

J. Stein, S. Arron, G. Klintmalm, 2017, JAMA dermatology.

Field Cancerization: Treatment.

S. Arron, A. Jambusaria-Pahlajani, C. Schmults, 2020, Journal of the American Academy of Dermatology.

Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.

C. Schmults, S. T. Que, F. Zwald, 2018, Journal of the American Academy of Dermatology.

Update on Evaluation and Management of High-Risk Squamous Cell Carcinomas

C. Schmults, B. Nguyen, 2014, Current Dermatology Reports.

Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.

M. Davids, C. Schmults, Jennifer R. Brown, 2014, JAMA dermatology.

Total Margin-Controlled Excision is Superior to Standard Excision for Keratinocyte Carcinoma on the Nose: A Veterans Affairs Nested Cohort Study

M. Mahalingam, C. Schmults, Sameer Gupta, 2021, Annals of Surgical Oncology.

Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma.

C. Schmults, P. Karia, E. Ruiz, 2019, JAMA dermatology.

A Review of Cutaneous Squamous Cell Carcinoma Epidemiology, Diagnosis, and Management

C. Schmults, E. Ruiz, S. Kabir, 2018 .

Evaluation of AJCC and an Alternative Tumor Classification System for Primary Vulvar Squamous Cell Carcinoma.

C. Feltmate, C. Schmults, B. Vollenhoven, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Merkel Cell Carcinoma , Version 1 . 2018 Clinical Practice Guidelines in Oncology

T. Olencki, I. Puzanov, A. Ho, 2018 .

Screening for nodal metastasis and its challenges: nodal needles in the SCC haystack.

C. Schmults, P. Karia, 2014, JAMA dermatology.

Provision of Trainee Biographies to Patients Before Mohs Micrographic Surgery Is Associated With Greater Patient Involvement by Trainees

C. Schmults, N. Nathan, E. Ruiz, 2020, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T cell exhaustion in reducing T cell responses

Jingwei Cheng, R. Clark, V. Huang, 2013, The Journal of investigative dermatology.

Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin.

R. Clark, T. Kupper, C. Schanbacher, 2009, The Journal of investigative dermatology.

Treatment Recommendations among Radiation Oncologists in the Treatment of Cutaneous Squamous Cell Carcinoma with Perineural Invasion

G. Laramore, J. Liao, A. Jambusaria-Pahlajani, 2016 .

Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma: A Systematic Review of the English Literature

C. Schmults, A. Ross, 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

An evaluation of high‐stage cutaneous squamous cell carcinoma outcomes by sex

C. Schmults, P. Karia, J. Duran, 2017, British Journal of Dermatology.

Complete Margin Assessment Versus Sectional Assessment in Surgically Excised High-Risk Keratinocyte Carcinomas: A Systematic Review and Meta-Analysis

C. Schmults, F. Murad, A. Waldman, 2022, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Treatment of metastatic cutaneous squamous cell carcinoma in a solid organ transplant recipient with programmed death‐1 checkpoint inhibitor therapy

C. Schmults, K. O’Connell, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Nodal staging of high-risk cutaneous squamous cell carcinoma.

Matthew C. Fox, K. Nehal, C. Schmults, 2019, Journal of the American Academy of Dermatology.

Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study.

A. Qureshi, Jiali Han, C. Schmults, 2013, JAMA dermatology.

Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis

A. Hauschild, D. Schadendorf, I. Lowy, 2021, Journal for ImmunoTherapy of Cancer.

Cutaneous Carcinoma of the Head and Neck

J. Shah, R. Weber, R. Seethala, 2017 .

Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study.

Matthew M. Johnson, C. Schmults, P. Karia, 2013, JAMA dermatology.

Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons.

A. Jambusaria-Pahlajani, C. Schmults, K. Katz, 2010, Archives of dermatology.

Management of high-risk cutaneous squamous cell carcinoma.

C. Schmults, L. Jennings, Lorraine M. Jennings, 2010, The Journal of clinical and aesthetic dermatology.

Diameter of Involved Nerves Predicts Outcomes in Cutaneous Squamous Cell Carcinoma with Perineural Invasion: An Investigator‐Blinded Retrospective Cohort Study

A. Troxel, C. Schmults, R. Elenitsas, 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Surgical Monotherapy Versus Surgery Plus Adjuvant Radiotherapy in High‐Risk Cutaneous Squamous Cell Carcinoma: A Systematic Review of Outcomes

Christopher J. Miller, H. Quon, A. Jambusaria-Pahlajani, 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

High-risk cutaneous squamous cell carcinoma: identification and management.

C. Schmults, 2005, Advances in dermatology.

A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change.

A. Jambusaria-Pahlajani, C. Schmults, C. Liang, 2014, Journal of the American Academy of Dermatology.

Identification of Skin Cancer Screening Visits Using Claims Data.

C. Schmults, P. Karia, E. Ruiz, 2020, Journal of the American Academy of Dermatology.

Evaluation of Pre-Operative Quality of Life in Non-Melanoma Skin Cancer Patients.

C. Schmults, J. Okhovat, P. Karia, 2019, Journal of the American Academy of Dermatology.

Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.

T. Olencki, I. Puzanov, A. Ho, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Metastatic eccrine porocarcinoma after Mohs micrographic surgery: a case report.

A. Ng, C. Schmults, Linda C. Wang, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012.

Jiali Han, C. Schmults, P. Karia, 2013, Journal of the American Academy of Dermatology.

A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.

D. Leaf, F. Hodi, P. Ott, 2020, Kidney international.

Diagnostic Biopsy via In-Office Frozen Sections for Clinical Nonmelanoma Skin Cancer.

C. Schmults, A. Piris, P. Mulvaney, 2021, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

NCCN Basal Cell Skin Cancer , Version 1 . 2016 Clinical Practice Guidelines in Oncology

T. Olencki, R. Cheney, A. Ho, 2016 .

Association of Nodal Metastasis and Mortality With Vermilion vs Cutaneous Lip Location in Cutaneous Squamous Cell Carcinoma of the Lip

S. Kraft, C. Schmults, G. Murphy, 2018, JAMA dermatology.

Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging.

C. Schmults, S. T. Que, F. Zwald, 2018, Journal of the American Academy of Dermatology.

PD‐1 Blockade with Cemiplimab in Advanced Cutaneous Squamous‐Cell Carcinoma

A. Hauschild, D. Schadendorf, C. Chung, 2018, The New England journal of medicine.

Detection of subclinical disease with baseline and surveillance imaging in high-risk cutaneous squamous cell carcinomas.

C. Schmults, C. Benson, P. Karia, 2020, Journal of the American Academy of Dermatology.

Evaluation of the utility of localized adjuvant radiation for node-negative primary cutaneous squamous cell carcinoma with clear histologic margins.

C. Schmults, S. Koyfman, S. T. Que, 2020, Journal of the American Academy of Dermatology.

Clinical and Incidental Perineural Invasion of Cutaneous Squamous Cell Carcinoma: A Systematic Review and Pooled Analysis of Outcomes Data

C. Schmults, P. Karia, E. Ruiz, 2017, JAMA dermatology.

Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Aleksandar Sekulic, Daniel Berg, Wade L Thorstad, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI)

J. Decaprio, N. LeBoeuf, C. Schmults, 2020, British Journal of Cancer.

Squamous Cell Carcinoma

N. LeBoeuf, C. Schmults, A. Werchniak, 2012 .

Validation of a 40-Gene Expression Profile Test to Predict Metastatic Risk in Localized High-Risk Cutaneous Squamous Cell Carcinoma.

S. Arron, D. Rigel, K. Covington, 2020, Journal of the American Academy of Dermatology.

Incidence and mortality for cutaneous squamous cell carcinoma: comparison across three continents

A. Stang, A. Green, C. Schmults, 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.

C. Schmults, P. Karia, D. Levine, 2015, JAMA dermatology.

Identifying BWH stage T2a cutaneous squamous cell carcinoma at risk for poor outcomes.

N. Gupta, C. Schmults, Rachel E. Weitzman, 2021, Journal of the American Academy of Dermatology.

Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma.

A. Qureshi, A. Jambusaria-Pahlajani, C. Schmults, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.

W. Hwang, F. M. Whalen, A. Jambusaria-Pahlajani, 2013, JAMA dermatology.

Comparison of Tumor Classifications for Cutaneous Squamous Cell Carcinoma of the Head and Neck in the 7th vs 8th Edition of the AJCC Cancer Staging Manual

J. Califano, C. Schmults, P. Karia, 2017, JAMA dermatology.

Treatment Patterns, Outcomes, and Patient Satisfaction of Primary Epidermally Limited Nonmelanoma Skin Cancer

C. Schmults, C. Liang, P. Karia, 2017, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

A Systematic Review of Primary, Adjuvant, and Salvage Radiation Therapy for Cutaneous Squamous Cell Carcinoma

C. Schmults, S. Koyfman, E. Ruiz, 2021, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.

C. Berking, A. Hauschild, D. Schadendorf, 2020, The Lancet. Oncology.

Surgery and Salvage Limited-Field Irradiation for Control of Cutaneous Squamous Cell Carcinoma With Microscopic Residual Disease.

C. Schmults, S. Koyfman, E. Ruiz, 2019, JAMA dermatology.

Update on the management of high-risk squamous cell carcinoma.

N. LeBoeuf, C. Schmults, 2011, Seminars in cutaneous medicine and surgery.

Staging and Management of High-Risk Cutaneous Squamous Cell Carcinoma

C. Schmults, P. Karia, E. Ruiz, 2015, Current Dermatology Reports.

Field Cancerization: Definition, epidemiology, risk factors, and outcomes.

S. Arron, A. Jambusaria-Pahlajani, C. Schmults, 2020, Journal of the American Academy of Dermatology.

Risk Stratification: Should All Actinic Keratoses in All Patients Be Treated?

C. Schmults, E. Ruiz, 2018, Current Dermatology Reports.

Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil.

C. Schmults, S. T. Que, L. Compton, 2019, Journal of the American Academy of Dermatology.

Histologic perineural invasion of unnamed nerves does not impact basal cell carcinoma outcomes.

C. Schmults, E. Ruiz, P. Massey, 2020, Journal of the American Academy of Dermatology.

Factors Predictive of Recurrence, Metastasis, and Death from Primary Basal Cell Carcinoma 2cm or Larger in Diameter.

V. Neel, C. Schmults, P. Karia, 2020, Journal of the American Academy of Dermatology.

Comment on: The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma—implications on the T‐classification system

A. Jambusaria-Pahlajani, C. Schmults, A. Parker, 2015, Journal of surgical oncology.

Cutaneous Squamous Cell Carcinoma.

C. Schmults, A. Waldman, 2019, Hematology/oncology clinics of North America.

Regulation of 5-hydroxymethylcytosine by TET2 contributes to Squamous Cell Carcinoma tumorigenesis.

C. Lian, Diana Wang, C. Schmults, 2021, The Journal of investigative dermatology.

CCAR2 Is Required for Proliferation and Tumor Maintenance in Human Squamous Cell Carcinoma.

C. Schmults, M. R. Ramsey, S. Best, 2017, The Journal of investigative dermatology.

Association Between Type of Reconstruction After Mohs Micrographic Surgery and Surgeon‐, Patient‐, and Tumor‐Specific Features: A Cross‐Sectional Study

A. Rademaker, K. Nehal, Murad Alam, 2013, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement.

Matthew C. Fox, S. Shumack, S. Arron, 2021, JAMA dermatology.

Brigham and Women's Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death.

V. Neel, C. Schmults, P. Karia, 2021, Journal of the American Academy of Dermatology.

Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinoma.

C. Schmults, E. Stockfleth, D. Ayers, 2020, Future oncology.

The positive impact of radiologic imaging on high‐stage cutaneous squamous cell carcinoma management

C. Schmults, P. Karia, E. Ruiz, 2017, Journal of the American Academy of Dermatology.

Upstaging of melanoma in situ and lentigo maligna treated with Mohs micrographic surgery rarely results in additional surgical management

C. Schmults, A. Waldman, M. Levoska, 2020, Archives of Dermatological Research.

Molecular prediction of metastasis in cutaneous squamous cell carcinoma.

C. Schmults, P. Mulvaney, 2019, Current opinion in oncology.

Efficacy of Liposomal Bupivacaine for Pain Control After Large, Complex Mohs Resections: A Matched Cohort Study

C. Schmults, F. Murad, Michael S Chang, 2022, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing

A. Hauschild, D. Schadendorf, I. Lowy, 2020, Journal for immunotherapy of cancer.

Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinoma.

L. Macconaill, N. LeBoeuf, C. Schmults, 2019, European journal of cancer.

Primary analysis of phase 2 results of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with locally advanced cutaneous squamous cell carcinoma (laCSCC).

C. Berking, A. Hauschild, D. Schadendorf, 2019, Journal of Clinical Oncology.

Phase 2 study of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with metastatic cutaneous squamous cell carcinoma (mCSCC; Group 1): 12-month follow-up.

A. Hauschild, I. Lowy, R. Gutzmer, 2019, Journal of Clinical Oncology.

Impact of corticosteroids on allograft protection in renal transplant patients receiving anti-PD-1 immunotherapy

C. Schmults, L. Riella, G. Hanna, 2020, Cancer Immunology and Immunotherapy.

Phase II study of cemiplimab in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC): Longer follow-up.

A. Hauschild, D. Schadendorf, I. Lowy, 2020 .

Efficacy and Cost Analysis for Acitretin for Basal and Squamous Cell Carcinoma Prophylaxis in Renal Transplant Recipients.

C. Schmults, P. Karia, E. Ruiz, 2020, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022.

M. Dwyer, R. Chin, I. Puzanov, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

A systematic review of patient-reported outcome measures for advanced skin cancer patients

C. Schmults, Erica H Lee, M. E. Reinhardt, 2022, Archives of Dermatological Research.

Treatment patterns and costs in cutaneous squamous cell carcinoma (CSCC) patients with nodal dissection, chemotherapy, and/or radiation therapy.

C. Schmults, Q. Harshaw, M. Fury, 2018 .

Cost and Utilization of Immunotherapy and Targeted Therapy for Melanoma: Cross-Sectional Analysis in the Medicare Population, 2013 and 2015.

C. Schmults, A. Silk, K. Seiger, 2020, Journal of the American Academy of Dermatology.

Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer.

C. Schmults, J. Azzi, E. Heher, 2016, JAMA dermatology.

Sequential Curettage, 5-Fluorouracil, and Photodynamic Therapy for Field Cancerization of the Scalp and Face in Solid Organ Transplant Recipients

A. Jambusaria-Pahlajani, C. Schmults, C. Liang, 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Change in Sun-Protective Behavior After Dermatologic Surgery for Skin Cancer in High-Risk Patients.

C. Schmults, S. Hurwitz, A. Waldman, 2019, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

The Sun Exposure and Behaviour Inventory (SEBI): validation of an instrument to assess sun exposure and sun protective practices

F. M. Whalen, A. Jambusaria-Pahlajani, C. Schmults, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

Improved Margin Control of Microcystic Adnexal Carcinoma After Mohs Micrographic Surgery Compared With Wide Local Excision.

C. Schmults, F. Murad, E. Ruiz, 2023, Dermatologic Surgery.

Impact of National Comprehensive Cancer Network Guidelines on Case Selection and Outcomes for Sentinel Lymph Node Biopsy in Thin Melanoma

C. Schmults, P. Karia, B. Nguyen, 2017, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Aneurysmal dermatofibroma successfully treated with Mohs micrographic surgery.

C. Schmults, P. Karia, Kareem Halim, 2015, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

A comparison of skin cancer screening and treatment costs at a Massachusetts cancer center, 2008 versus 2013

P. Ott, Jennifer Y. Lin, C. Schmults, 2018, Journal of the American Academy of Dermatology.

A comparison of high- and low-cost infection-control practices in dermatologic surgery.

C. Schmults, E. Lilly, 2012, Archives of dermatology.

Heightened Infection‐Control Practices are Associated with Significantly Lower Infection Rates in Office‐Based Mohs Surgery

C. Schmults, Lark-Aeryn Speyer, Julie E. Martin, 2010, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

TMeB score may improve risk stratification of high‐risk cutaneous squamous cell carcinoma and guide management of patients: A pilot study

M. Mendiburu-Eliçabe, J. Pérez-Losada, C. Schmults, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Implications of Satellitosis or In-transit Metastasis in Cutaneous Squamous Cell Carcinoma: A Prognostic Omission in Cancer Staging Systems.

C. Schmults, S. Koyfman, A. Vidimos, 2022, JAMA dermatology.

Cutaneous squamous cell carcinoma staging may influence management in users: A survey study

S. Arron, A. Jambusaria-Pahlajani, C. Schmults, 2021, Cancer medicine.

Risk Factors Party Together: The Role of Perineural Invasion and Desmoplasia in Cutaneous Squamous Cell Carcinoma Prognosis.

A. Jambusaria-Pahlajani, C. Schmults, P. Karia, 2020, The Journal of investigative dermatology.

An ecological study of skin biopsies and skin cancer treatment procedures in the United States Medicare population, 2000 to 2015

C. Schmults, R. Besaw, F. Morgan, 2018, Journal of the American Academy of Dermatology.

PRMT1 Inhibition Selectively Targets BNC1-Dependent Proliferation, but not Migration in Squamous Cell Carcinoma

C. Lian, Diana Wang, C. Schmults, 2023, bioRxiv.

Modified peripheral and central Mohs micrographic surgery for improved margin control in extramammary Paget disease

C. Feltmate, C. Schmults, M. Danesh, 2020, JAAD Case Reports.

Impact of COVID-19 delays on skin cancer worry and Mohs micrographic surgery for keratinocytic carcinoma

A. Rossi, K. Nehal, C. Schmults, 2021, Journal of the American Academy of Dermatology.

Multiple Mohs micrographic surgery is the most common reason for divergence from the appropriate use criteria: A single institution retrospective cohort study.

C. Schmults, C. Liang, P. Karia, 2016, Journal of the American Academy of Dermatology.

Higher metastasis and death rates in cutaneous squamous cell carcinomas with lymphovascular invasion.

C. Schmults, S. Koyfman, A. Vidimos, 2021, Journal of American Academy of Dermatology.

A Matched-Pair Study of Cutaneous Squamous Cell Carcinomas with and without Lymphovascular Invasion.

C. Schmults, F. Murad, E. Ruiz, 2020, Journal of American Academy of Dermatology.

Accuracy of death certification in cutaneous squamous cell carcinoma: A retrospective case review

C. Schmults, P. Karia, R. Besaw, 2018, Journal of the American Academy of Dermatology.

Adjuvant radiation following clear margin resection of high T-stage cutaneous squamous cell carcinoma halves the risk of local and locoregional recurrence: A dual center retrospective study.

R. Tishler, C. Schmults, S. Koyfman, 2022, Journal of the American Academy of Dermatology.

Cutaneous Squamous Cell Carcinoma.

C. Schmults, A. Waldman, 2019, Hematology/oncology clinics of North America.

Practice Variation in Utilization of Flap or Graft Reconstruction Among Veterans Affairs Surgeons After Extirpation of Keratinocyte Carcinoma on the Nose

C. Schmults, Sameer Gupta, K. Sigel, 2021, Dermatologic Surgery.

Analysis of national skin cancer expenditures in the United States Medicare population, 2013

Corwin M Zigler, C. Schmults, E. Ruiz, 2019, Journal of the American Academy of Dermatology.

Skin Cancer after Ruxolitinib or Belumosudil. Reply.

C. Schmults, 2023, New England Journal of Medicine.

A multistep approach to improving biopsy site identification in dermatology: physician, staff, and patient roles based on a Delphi consensus.

K. Nehal, E. Poon, M. Nodzenski, 2014, JAMA dermatology.

Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012.

Jiali Han, C. Schmults, Pritesh S. Karia, 2013, Journal of the American Academy of Dermatology.

A proposed grading system for desmoplasia in cutaneous squamous cell carcinoma predicts death from disease.

C. Schmults, A. Piris, F. Murad, 2023, Journal of Investigative Dermatology.

Squamous Cell Carcinoma: An Update in Staging, Management, and Postoperative Surveillance Strategies.

C. Schmults, Anthony K. Guzman, Emily S. Ruiz, 2022, Dermatologic clinics.

Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.

K. Nehal, C. Schmults, A. Sekulic, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.

Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin.

R. Clark, T. Kupper, C. Schanbacher, 2009, The Journal of investigative dermatology.

NCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024.

K. Nehal, C. Schmults, A. Sekulic, 2024, Journal of the National Comprehensive Cancer Network : JNCCN.

Peri-operative imaging for high-stage cutaneous squamous cell carcinoma helps guide management in nearly a third of cases: a single-institution retrospective cohort.

C. Schmults, E. Granger, F. Murad, 2023, Journal of the American Academy of Dermatology.

High-Risk Cutaneous Squamous Cell Carcinoma

C. Schmults, 2016 .

Immune status does not independently influence cutaneous squamous cell carcinoma metastasis and death when stratified by tumor stage: A dual center retrospective cohort analysis of primary N0 disease.

C. Schmults, S. Koyfman, A. Vidimos, 2022, Journal of American Academy of Dermatology.

Education and Perspectives on the Use of Oral Skin Cancer Chemoprophylaxis: A Cross-Sectional Survey of Current Fellows in Mohs Micrographic Surgery & Dermatologic Oncology

C. Schmults, Anthony K. Guzman, E. S. Ruiz, 2023, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Extensive Perineural Invasion vs Nerve Caliber to Assess Cutaneous Squamous Cell Carcinoma Prognosis.

C. Schmults, J. Okhovat, F. Murad, 2023, JAMA dermatology.

Factors predictive of recurrence, metastasis and death in node-negative penile squamous cell carcinoma: A retrospective multicentre cohort study.

C. Schmults, M. Mossanen, F. Murad, 2024, Journal of the European Academy of Dermatology and Venereology : JEADV.

Total Margin Control Is Superior to Traditional Margin Assessment for Treatment of Low-Stage Penile Squamous Cell Carcinoma

G. Sonpavde, C. Schmults, M. Mossanen, 2023, The Journal of urology.

High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma

I. Lowy, N. Basset-Seguin, C. Schmults, 2024, Journal for ImmunoTherapy of Cancer.